You are here

Lannett

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011

Seeking Alpha

Tue, 12/28/10 - 11:58 am

What Investors Think About Lannett

Motley Fool

Thu, 07/22/10 - 09:51 am

FDA approves Lannett’s generic for Sandoz weight-loss drug

Bizjournals.com

Tue, 07/20/10 - 03:31 pm

Lannett gets FDA approval for generic Zofran

Yahoo/AP

Mon, 04/19/10 - 05:52 pm

Lannett to Submit NDA for Morphine Sulfate Products

Trading Markets

Sat, 02/6/10 - 12:40 pm

morphine sulfate

Lannett gets OK for gallstones drug

Bizjournals.com

Tue, 12/16/08 - 05:29 pm

Watson Pharmaceuticals

Pages